Done. I re-reviewed only `doi__10.1093_molbev_msn208` and left it non-accepted.

Key outcome: local XML/PDF/OA Figure 2/supplement/database review supports Brevinin-1PLa identity/sequence context, but no local primary activity/toxicity assay row supports the DRAMP Bd `MIC=50 µM` annotation. I preserved that as database-derived/source-conflict evidence, recorded `unrecoverable_material_gaps`, and kept ticket `rwk-complete-test-0001` open as `blocked_unrecoverable_after_best_effort`.

Updated the owned packet/final/work/rework artifacts, including:
`paper_packets/.../analysis/*`, `paper_packets/.../final/*`, `papers/.../final/*`, `papers/.../work/review/quality_feedback.json`, and `paper_packets/.../rework/{rework_requests,rework_responses}.jsonl`.

Validation evidence:
- JSON validation passed for repaired artifacts.
- Semantic gate rerun: `0/1` pass; issue codes are `review_status_not_publication_grade`, `publication_grade_not_true`, `missing_activity_records`.
- Publication-quality gate rerun: `publication_grade_pass=false`, `open_rework_targets=1`.
- Packet checker rerun: `hard_finding_count=0`, material layer still separate as `material_extracted_with_gaps`, analysis now `analysis_blocked_unrecoverable_material_gaps`.

